Trial intelligence / Profile preview

Ondansetron vs Prochlorperazine for Nausea and Vomiting in the ED

NCT00590317Phase 2Completed

Sponsor
Emory University
Start
Mar 2005
Primary completion
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of ondansetron in nausea ((none)) and Vomiting (2 arms), sponsored by Emory University. Primary endpoint: Vomiting at 0 to 120 Min. Started Mar 2005; status: completed.

02

Drugs

ondansetron
03

Conditions

nausea ((none))Vomiting

Beyond the preview

Go deeper on NCT00590317.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00590317.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call